Description: Grey Wolf Animal Health Inc. provides products, solutions, and services for the health of animals in Canada and internationally. The company provides products such as Pharmaceuticals which includes sedaject, ataject, and thyro-tabs canine; nutraceuticals, which include composure pro, vertiflex, hide and treat, Bioflex active, Bioflex ultra, and glucosamine; and consumables which includes medical pet shirt protective wear that comprise pet shirt, pets boot, head cover, and leg sleeves; wound healing products, inclusing activon tube, actilite, algivon, algivon plus ribbon, advazorb, silfix, eclypse, eclypse adherent, eclypse border, silflex, and siltape; and disposables comprising syringes, needles, and iv catheters. Grey Wolf Animal Health Inc. was founded in 2015 and is headquartered in Toronto, Canada.
Home Page: www.greywolfah.com
WOLF Technical Analysis
65 Front Street East
Toronto,
ON
M5E 1B5
Canada
Phone:
Officers
| Name | Title |
|---|---|
| Ms. Angela Cechetto | Chief Exec. Officer |
| Dr. Ian Sandler | Founder, Director & CVMO |
| Mr. Kevin S. Palmer C.A., CPA, M.B.A. | Chief Financial Officer |
| Mr. Brandon Mair-Wren | VP of Operations |
| Mr. Murray Roach | C.C.O. |
Exchange: V
Country: CA
Currency: Canadian Dollar (C$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 1.2631 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 40 |